Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Gianvag AB
AB
Active
Org 5593895146
Skepparegatan 11, 602 27
Norrköping
General medical practice activities
· NACE 8621
Est. 2022
1 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Gianvag AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
798
228
Staff expenses
−5
−1
EBITDA
734
185
Depreciation & amort.
−14
−10
EBIT
720
175
Net financials
6
14
Profit before tax
726
188
Tax
−150
−39
Net profit
576
150
Balance sheet
SEK thousands
Item
2023
2024
Total assets
747
789
Equity
601
751
Long-term debt
—
—
Short-term debt
146
39
Total debt
146
39
Financial ratios
5-year trend
EBITDA margin
80.9%
This company
15.8%
Market median
+412% vs market
2023
2024
Equity ratio
95.1%
This company
38.2%
Market median
+149% vs market
2023
2024
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
2023
2024
Net profit margin
65.5%
This company
8.1%
Market median
+709% vs market
2023
2024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
2023
2024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-13 – 2023-12-31
View
PDF
More on Gianvag AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
